Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Announces Quarterly Dividend of $0.25

Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) declared a quarterly dividend on Thursday, April 25th, Zacks reports. Stockholders of record on Tuesday, May 21st will be given a dividend of 0.25 per share by the pharmacy operator on Wednesday, June 12th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.65%. The ex-dividend date of this dividend is Monday, May 20th.

Walgreens Boots Alliance has raised its dividend payment by an average of 1.3% per year over the last three years. Walgreens Boots Alliance has a dividend payout ratio of 31.3% meaning its dividend is sufficiently covered by earnings. Research analysts expect Walgreens Boots Alliance to earn $3.13 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 31.9%.

Walgreens Boots Alliance Trading Up 0.6 %

Walgreens Boots Alliance stock traded up $0.10 during midday trading on Friday, reaching $17.70. 6,592,036 shares of the stock traded hands, compared to its average volume of 13,083,050. The company has a 50-day simple moving average of $20.01 and a two-hundred day simple moving average of $21.77. Walgreens Boots Alliance has a 12-month low of $17.49 and a 12-month high of $35.38. The firm has a market cap of $15.27 billion, a PE ratio of -2.53, a price-to-earnings-growth ratio of 1.09 and a beta of 0.73. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating analysts' consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company had revenue of $37.05 billion during the quarter, compared to analysts' expectations of $35.86 billion. During the same period last year, the business posted $1.16 EPS. Walgreens Boots Alliance's revenue for the quarter was up 6.3% on a year-over-year basis. Research analysts expect that Walgreens Boots Alliance will post 3.23 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on WBA. Bank of America dropped their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set an "underperform" rating on the stock in a report on Tuesday, March 26th. Morgan Stanley dropped their target price on Walgreens Boots Alliance from $21.00 to $20.00 and set an "underweight" rating on the stock in a report on Monday, April 1st. Barclays began coverage on Walgreens Boots Alliance in a report on Wednesday, January 3rd. They issued an "underweight" rating and a $21.00 target price on the stock. Truist Financial reissued a "hold" rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Finally, UBS Group dropped their target price on Walgreens Boots Alliance from $25.00 to $22.00 and set a "neutral" rating on the stock in a report on Wednesday, April 3rd. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of "Hold" and an average price target of $24.36.

Insiders Place Their Bets

In other news, Director Inderpal S. Bhandari bought 3,000 shares of the firm's stock in a transaction on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Inderpal S. Bhandari bought 3,000 shares of the firm's stock in a transaction on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Valerie B. Jarrett bought 4,456 shares of the firm's stock in a transaction on Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the transaction, the director now owns 4,456 shares of the company's stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 13,456 shares of company stock worth $270,423. 17.40% of the stock is owned by corporate insiders.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.